NEW YORK (Reuters Health) – After surgery for stage III colon cancer, adjuvant chemotherapy reduces the risk of distant recurrence by about half, and elderly patients benefit to…
NEW YORK (Reuters Health) – The addition of bevacizumab to adjuvant chemotherapy does not improve invasive disease-free rates in women after resection of breast cancer that’s negative for…
By Will Boggs, MD NEW YORK (Reuters Health) – Patients with unresectable primary spinal sarcoma may benefit from carbon ion radiotherapy (CIRT), Japanese researchers say. Compared with proton…
Hepatitis C is a virus that causes liver inflammation. If not treated effectively it can lead to cirrhosis, liver failure, and even death. A new study tested whether…
Ever wondered what you and your patients were really getting from the Patient Protection and Affordable Care Act? A new blog by NYC neurologist, Dr. Anthony Geraci, explores…
Jay S. Duker, MD, Director of the New England Eye Center, discusses the unmet need for patients with wet and dry macular degeneration. Dr. Duker discusses alternative forms of…
Jay S. Duker, MD, Director of the New England Eye Center, discusses the AREDS studies, which aimed to determine the causes of age-related macular degeneration and the modification of those…
NEW YORK (Reuters Health) – Bevacizumab appears to be most effective for metastatic colorectal cancer when the primary tumor originates distally, according to a Danish study. However, the…
NEW YORK (Reuters Health) – Recurrence after limited lung resection for small early-stage adenocarcinoma is three times more likely when the micropapillary component of the tumor is 5%…
Hypertension or high blood pressure affects 65 million Americans. Uncontrolled, it can put people at risk for heart attack and stroke. A new study examined how a large-scale…
Jay S. Duker, MD, Director of the New England Eye Center, discusses the characteristics and complications of age-related macular degeneration as well as the evolution of treatments for AMD,…
NEW YORK (Reuters Health) – The addition of aprepitant to anti-emesis treatment seems to reduce the occurrence of nausea and vomiting among patients who are likely to experience…
